Future Financial Wealth Managment »

Apellis Pharmaceuticals shares owned by Future Financial Wealth Managment

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Future Financial Wealth Managment from 13F filings

Historical chart of Future Financial Wealth Managment investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Future Financial Wealth Managment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Future Financial Wealth Managment

Quarter filed Position value Share count Share price at filing
2024-09-30 $14k 500 28.84
2024-03-31 $29k 500 58.78
2022-03-31 $25k 500 50.00
2021-12-31 $24k 500 48.00

More positions owned by Future Financial Wealth Managment

Vanguard S&p 500 Etf Etf (VOO)
Invesco Nasdaq 100 Etf Etf (QQQM)
Schwab Us Dividend Equity Etf Etf (SCHD)
Ishares Russell Top 200 Growth Etf Etf (IWY)
Procter And Gamble Stock (PG)
Pacer Us Cash Cows 100 Etf Etf (COWZ)
Vaneck Vectors MS Wide Moat Etf (MOAT)
T. Rowe Price U.s. Equity Research Etf Etf (TSPA)
Ishares Currency Hedged Msci Eafe Etf Etf (HEFA)
Vaneck Preferred Securities Ex Financials Etf Etf (PFXF)
Janus Detroit Street Trust Janus Henderson Aaa Clo Etf Etf (JAAA)
Ishares 0-5 Year High Yield Corporate Bond Etf Etf (SHYG)
Apple Stock (AAPL)
Technology Select Sector Spdr Fund Etf (XLK)
Jpmorgan Ultra-short Income Etf Etf (JPST)

View all positions for Future Financial Wealth Managment

Top funds holding Apellis Pharmaceuticals

BlackRock
Jpmorgan Chase & Co
Braidwell
Octagon Capital Advisors
T. Rowe Price Investment Management
Siren
Assenagon Asset Management
Jennison Associates
Geode Capital Management
Deutsche Bank Aktiengesellschaft
Boxer Capital
Fiera Capital Corporation
OrbiMed Advisors
Susquehanna International
Bank of America Corporation

View all funds holding Apellis Pharmaceuticals